Clinical Trial Update: A Study of Self-administered Misoprostol to Prevent Bleeding After Childbirth in the Community (MamaMiso) [NA]

View source ↗

Summary

This update covers the MamaMiso trial testing self-administered misoprostol to prevent postpartum hemorrhage after childbirth in community settings; the trial s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• MISOPROSTOL (Misoprostol)

Snippet

Sponsor: Gynuity Health Projects | Conditions: Postpartum Hemorrhage | NA | Status: COMPLETED